Score
Based on recent headline ratings, % of this readership currently trusts the local media, which has an average score of % regionally and is currently trending .
Media Trust Score%

Shionogi Files for Approval of S-268019, a COVID19 Recombinant Protein-based Vaccine, in Japan

Shionogi Files for Approval of S-268019, a COVID19 Recombinant Protein-based Vaccine, in Japan. OSAKA, Japan, November 24, 2022 – Shionogi & Co., …

  • You already voted!
  • Read More